What is Rawsome?
Rawsome operates at the intersection of natural wellness and consumer packaged goods, specializing in a diverse portfolio of CBD-infused products. Their catalog, which includes tinctures, gummies, balms, and roll-ons, is formulated with organic ingredients to address specific consumer pain points such as anxiety, joint discomfort, and dermatological concerns. By prioritizing high-quality sourcing and customer-centric service, Rawsome has carved out a distinct niche in the Texas market, positioning itself as a reliable provider for individuals seeking holistic alternatives to traditional pharmaceutical interventions. The company's focus on varying strengths and sizes allows for a personalized approach to CBD consumption, catering to both novice users and experienced wellness enthusiasts.
How much funding has Rawsome raised?
Rawsome has raised a total of $323K across 2 funding rounds:
Debt
$150K
Debt
$173K
Debt (2020): $150K with participation from PPP
Debt (2021): $173K led by PPP
Key Investors in Rawsome
PPP
Public-Private Partnership
What's next for Rawsome?
With the infusion of $173K, Rawsome is well-positioned to accelerate its market penetration and refine its supply chain logistics. The strategic deployment of this capital will likely focus on expanding distribution channels and enhancing product development to meet the evolving regulatory and consumer demands of the CBD industry. As the company transitions through this late-stage growth phase, the focus will shift toward optimizing operational efficiencies and solidifying its brand presence in a crowded marketplace. Future initiatives may include scaling digital marketing efforts and exploring new product categories that align with the company's core mission of providing natural, effective relief solutions to a broader demographic.
See full Rawsome company page
